Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK / PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Xianhui Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Affiliated Women's Hospital of Jiangnan University, Wuxi Maternity and Child Health Care Hospital, Wuxi, China. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Hyperoxia, Ferroptosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Commission of Health and Family Planning, Medical Key Discipline Program of Wuxi Health Commission.
Abstract (Originalsprache)
Quercetin, a bioactive natural compound renowned for its potent anti‐inflammatory, antioxidant, and antiviral properties, has exhibited therapeutic potential in various diseases. Given that bronchopulmonary dysplasia (BPD) development is closely linked to inflammation and oxidative stress, and quercetin, a robust antioxidant known to activate NRF2 and influence the ferroptosis pathway, offers promise for a wide range of age groups. Nonetheless, the specific role of quercetin in BPD remains largely unexplored. This study aims to uncover the target role of quercetin in BPD through a combination of network pharmacology, molecular docking, computer analyses, and experimental evaluations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Affiliated Women's Hospital of Jiangnan University, Wuxi Maternity and Child Health Care Hospital, Wuxi, China.
- Department of Physiopathology, Wuxi School of Medicine, Jiangnan University, Wuxi, China.
- Research Institute for Reproductive Health and Genetic Diseases, Affiliated Women's Hospital of Jiangnan University, Wuxi, China.
- Department of Pediatric, Wuxi Yihe Gynaecology and Obstetrics Hospital, Wuxi, China.
Förderung
- National Natural Science Foundation of China
- Jiangsu Commission of Health and Family Planning
- Medical Key Discipline Program of Wuxi Health Commission
Zitieren
APA
Deng, X., Chen, D., Xie, A., Li, S., Chen, A., Zhou, Q., & Yu, R. (2024). Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK / PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14520
Vancouver
Deng X, Chen D, Xie A, Li S, Chen A, Zhou Q, et al. Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK / PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14520
BibTeX
@article{Deng2024,
author = {Deng, Xianhui and Chen, Dan and Xie, Anni and Li, Shengpeng and Chen, Ailing and Zhou, Qin and Yu, Renqiang},
title = {Quercetin alleviates hyperoxia‐induced bronchopulmonary dysplasia by inhibiting ferroptosis through the MAPK / PTGS2 pathway: Insights from network pharmacology, molecular docking, and experimental evaluations},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14520}
}
EUVIMED